Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,338 | 54,728 | 57,897 | 41,039 | 43,837 |
| TOTAL | $51,650 | $55,040 | $58,207 | $41,439 | $44,166 |
| Non-Current Assets | |||||
| PPE Net | 635 | 618 | 599 | 490 | 395 |
| Other Non-Current Assets | 1,939 | 2,041 | 366 | 423 | 494 |
| TOTAL | $2,574 | $2,659 | $965 | $913 | $889 |
| Total Assets | $54,224 | $57,699 | $59,172 | $42,352 | $45,055 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 557 | 560 | 394 | 309 | 709 |
| Accrued Expenses | 416 | 729 | 359 | 413 | 532 |
| TOTAL | $1,270 | $1,580 | $1,118 | $1,393 | $1,874 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 33 | 33 | N/A |
| Other Non-Current Liabilities | 1,637 | 1,715 | 0 | 85 | 169 |
| TOTAL | $1,637 | $1,715 | $N/A | $85 | $169 |
| Total Liabilities | $2,907 | $3,295 | $1,118 | $1,478 | $2,043 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 270 | 270 | 270 | 243 | 243 |
| Retained earnings | -87,181 | -81,851 | -72,864 | -70,474 | -68,096 |
| TOTAL | $51,317 | $54,404 | $58,054 | $40,874 | $43,012 |
| Total Liabilities And Equity | $54,224 | $57,699 | $59,172 | $42,352 | $45,055 |